Taisho Pharmaceutical Co., Ltd.
🇯🇵Japan
A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy
- First Posted Date
- 2017-08-30
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT03267303
- Locations
- 🇰🇷
Taisho Pharmaceutical Co., Ltd selected site, Seoul And Other Korean City, Korea, Republic of
Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2010-03-19
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 39
- Registration Number
- NCT00876304
- Locations
- 🇺🇸
Pfizer Investigational Site, Glendale, California, United States
A Study Of The Effect Of PF-04802540 On Sleep Measures
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2010-03-19
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT00772512
- Locations
- 🇺🇸
Pfizer Investigational Site, New York, New York, United States
Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2010-03-19
- Lead Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00756743
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
© Copyright 2024. All Rights Reserved by MedPath